Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125376352 | 12537635 | 2 | F | 20000602 | 20160628 | 20160707 | 20160710 | EXP | GB-TEVA-672075ACC | TEVA | 49.00 | YR | M | Y | 0.00000 | 20160710 | CN | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125376352 | 12537635 | 1 | PS | PAROXETINE. | PAROXETINE | 1 | 40 MILLIGRAM DAILY; 20 MG, BID | U | U | 76618 | 20 | MG | TABLET | BID | |||||
125376352 | 12537635 | 2 | SS | PAROXETINE. | PAROXETINE | 1 | 20 MILLIGRAM DAILY; 20 MG, QD | U | U | 76618 | 20 | MG | TABLET | QD | |||||
125376352 | 12537635 | 3 | SS | PAROXETINE HYDROCHLORIDE. | PAROXETINE HYDROCHLORIDE | 1 | Unknown | U | U | 0 | TABLET | ||||||||
125376352 | 12537635 | 4 | SS | PAXIL | PAROXETINE HYDROCHLORIDE | 1 | 25 MILLIGRAM DAILY; | U | U | 0 | 25 | MG | TABLET | QD | |||||
125376352 | 12537635 | 5 | SS | PAXIL | PAROXETINE HYDROCHLORIDE | 1 | UNK | U | U | 0 | TABLET | ||||||||
125376352 | 12537635 | 6 | SS | PAXIL | PAROXETINE HYDROCHLORIDE | 1 | 40 MILLIGRAM DAILY; | U | U | 0 | 20 | MG | TABLET | BID | |||||
125376352 | 12537635 | 7 | SS | PAXIL | PAROXETINE HYDROCHLORIDE | 1 | 20 MILLIGRAM DAILY; | U | U | 0 | 20 | MG | TABLET | QD | |||||
125376352 | 12537635 | 8 | SS | PAXIL | PAROXETINE HYDROCHLORIDE | 1 | 40 MILLIGRAM DAILY; | U | U | 0 | 20 | MG | TABLET | BID | |||||
125376352 | 12537635 | 9 | C | CIPRAMIL | CITALOPRAM HYDROBROMIDE | 1 | UNK | 0 | |||||||||||
125376352 | 12537635 | 10 | C | EFFEXOR | VENLAFAXINE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
125376352 | 12537635 | 11 | C | PROTHIADEN | DOTHIEPIN HYDROCHLORIDE | 1 | UNK | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125376352 | 12537635 | 1 | Product used for unknown indication |
125376352 | 12537635 | 3 | Panic attack |
125376352 | 12537635 | 4 | Depression |
125376352 | 12537635 | 5 | Product used for unknown indication |
125376352 | 12537635 | 9 | Product used for unknown indication |
125376352 | 12537635 | 10 | Product used for unknown indication |
125376352 | 12537635 | 11 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125376352 | 12537635 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125376352 | 12537635 | Agitation | |
125376352 | 12537635 | Blindness transient | |
125376352 | 12537635 | Disturbance in attention | |
125376352 | 12537635 | Dizziness | |
125376352 | 12537635 | Drug withdrawal syndrome | |
125376352 | 12537635 | Fatigue | |
125376352 | 12537635 | Irritability | |
125376352 | 12537635 | Memory impairment | |
125376352 | 12537635 | Metamorphopsia | |
125376352 | 12537635 | Mood swings | |
125376352 | 12537635 | Nightmare | |
125376352 | 12537635 | Paraesthesia | |
125376352 | 12537635 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125376352 | 12537635 | 3 | 19980603 | 0 | ||
125376352 | 12537635 | 4 | 20150630 | 0 | ||
125376352 | 12537635 | 6 | 20070831 | 20100729 | 0 | |
125376352 | 12537635 | 7 | 20100810 | 20151022 | 0 | |
125376352 | 12537635 | 8 | 20061213 | 20070730 | 0 | |
125376352 | 12537635 | 9 | 19960917 | 0 | ||
125376352 | 12537635 | 10 | 19980601 | 0 |